Stryker Archives - Page 3 of 17 - Medical Design Sourcing

Stryker unveils next-gen minimally invasive surgical camera

The 1788 camera. [Image courtesy of Stryker]Stryker (NYSE: SYK) + announced today that it unveiled its next-generation 1788 surgical camera platform.

Kalamazoo, Michigan-based Stryker designed the fully enhanced, minimally invasive camera to advance surgery across multiple specialties.

The all-in-one surgical camera platform offers more vibrant images with balanced lighting. It also features a wider color gamut and clearer delineation of fluorescence signals, Stryker said in a news release. The company says the camera improves the visualization of blood flow and critical anatomy, visualizing multiple optical imaging agents.

Dr. Matthew Albert, colon and rectal surgeon at Advent Health, said dependable imaging represents one of the most critical factors in surgical outcomes.

“With the enhanced imaging capabilities of the 1788, surgeons have a complete surgical camera technology that provides consistent …

AdvaMed takes aim at device lawsuits funded by third parties

The Advanced Medical Technology Association (AdvaMed) is asking for new regulations to protect device manufacturers from lawsuits bankrolled by third-party funders.

Ahead of a U.S. House Committee on Oversight and Accountability hearing on the topic tomorrow, AdvaMed General Counsel and Chief Policy Officer Chris White submitted a letter in which he said “most mass tort litigation against medical device manufacturers is fueled by banks, private equity firms and hedge funds.”

AdvaMed wants new federal regulations of mass tort advertising like laws passed in Tennessee and Texas.

“The influx of billions of dollars of third-party litigation funding has fundamentally changed the dynamics of mass tort litigation,” White wrote. “These financiers are injecting huge amounts of investment capital into creating litigation regardless of the merits,” White wrote in the letter. “They start by funding mass marketing campaigns on TV, radio,…

FDA clears Pangea trauma systems from Stryker

Stryker (NYSE:SYK) announced today that its Pangea systems — including femur, fibula, tibia, humerus and utility — received FDA 510(k) clearance.

Kalamazoo, Michigan-based Stryker designed its Pangea systems with collaborative efforts from world-renowned orthopedic surgeons. The plates offer an evidence-based design for implant fit.

The company said in a news release that it designed the system to enhance plate fit and screw placement. It also elevates the plating market through anatomically contoured implants in patient populations with a wide variety of fracture patterns. Stryker says its intuitive and streamlined instrumentation and implant trays include 20 anatomic plates and 13 utility plates. The company made them all accessible through just the one platform.

Stryker plans to feature its Pangea systems at the Annual Orthopaedic Trauma Association next month in Seattle.

“FDA clearance is a critical milestone for our Pangea Systems,” said Eric…

What are the largest medical device companies?

Medtronic, Johnson & Johnson MedTech and Siemens Healthineers again lead the Medtech Big 100 list of largest medical device companies.

However, there is so much more to Medical Design & Outsourcing and MassDevice‘s 2023 edition of the Medtech Big 100 report. We pulled thousands of data points to provide information on annual revenue, R&D spending, headcount, CEOs and key leaders, headquarters locations and descriptions of each of the 100 largest medical device companies.

Senior Editor Danielle Kirsh’s analysis shows that even as the largest medtech companies engaged in layoffs over the past year, they also made a bet on innovation to boost future growth: R&D spending increased nearly 13% to $26.4 billion. (Read the full story on MDO.)

In addition, the full Medtech Big 100 list includes already completed medtech company spinoffs such as Embecta , GE HealthCare and ZimVie.

Read the full Medtech Big 100 report to find out …

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]

Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker and Zimmer Biomet both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product launches between this year and the end of 2025, the …

The 10 largest orthopedic device companies in the world

The goal of Stryker’s Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker] Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year.

Stryker (NYSE: SYK) + and Zimmer Biomet (NYSE: ZBH) + both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic.

GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 billion this year. The question is whether companies can continue the momentum. Stryker and ZB are betting on innovation, building arrays of products and services around their surgical robotics systems and surgical planning and digital health tools.

During Zimmer Biomet’s second-quarter earnings call, CEO Bryan Hanson noted that ZB has 40 planned product …

Stryker launches direct-to-patient marketing campaign for Mako surgical robot

[Image courtesy of Stryker]Stryker (NYSE: SYK) + announced today that it launched a nationwide, direct-to-patient marketing campaign.

The “Scan. Plan. Mako Can.” marketing campaign aims to drive patient awareness of its Mako SmartRobotics platform. The surgical robotic system offers an option for those who need joint replacement surgery due to arthritis of the knee or hip.

“‘Scan. Plan. Mako Can.’ is rooted in the foundation of Mako SmartRobotics,” said Don Payerle, president of Stryker’s Joint Replacement division. “We have an unwavering commitment to revolutionizing joint replacement technology and enabling surgeons to achieve enhanced outcomes for their patients. We are eager to share this campaign with patients experiencing joint pain so they can seek care and begin their journey towards returning to the activities they love.”

The campaign promotes CT-based …

Stryker surpasses Q2 forecasts, boosts full-year outlook

Stryker (NYSE: SYK) + this evening reported second-quarter results that beat the Wall Street consensus forecast, prompting it to up its full-year guidance.

The Kalamazoo, Michigan–based orthopedic device giant reported an 11.2% year-over-year increase in Q2 sales to $5.0 billion, surpassing the analysts’ anticipated revenue of $4.82 billion. Earnings were up 12.% to $738 million for the quarter ended June 20, 2023.

Stryker reported EPS growth of 12.2% to $1.93, with adjusted EPS up 12.9% to $2.54, beating The Street’s consensus of $2.38 by 16¢.

“We delivered strong organic sales growth in the second quarter as demand for our products remains strong,” CEO Kevin Lobo said in a news release. “We are back on our margin expansion pathway, and our supercycle of innovation is going well.”

Both of Stryker’s business segments exhibited strong performance. MedSurg and Neuro…

Stryker launches Q guidance with cranial guidance software

A surgeon uses the Q Guidance System with cranial guidance software. [Image courtesy of Stryker]Stryker (NYSE: SYK) + announced today that it launched its Q Guidance System with cranial guidance software.

The Kalamazoo, Michigan-based orthopedic giant began surveillance cases for the platform in May. Stryker designed the Q Guidance System as an image-based planning and intraoperative platform. The company launched the system for spinal applications in September 2022. This latest iteration offers support for cranial surgeries. Stryker received FDA clearance for it in February.

Q Guidance with cranial guidance software provides assistance in instrument positioning and patient anatomy identification during cranial surgery. Uses include for craniotomies, skull base and transsphenoidal procedures, plus shunt placements and biopsies.

This launch comes on the heels of last week’s Ortho Q fully autonomous guidance sy…

Stryker launches Ortho Q fully autonomous guidance system

The Ortho Q guidance system with Ortho Guidance software. [Image courtesy of Stryker]Stryker (NYSE: SYK) + announced today that it launched its Ortho Q guidance system.

Kalamazoo, Michigan-based Stryker says Ortho Q is the only fully autonomous system in the industry. Surgeons can easily control the platform from the sterile field. It combines new optical tracking options through a redesigned, state-of-the-art camera.

According to a news release, Ortho Q features sophisticated algorithms as part of the new software. This helps to deliver additional surgical planning and guidance capabilities. Ortho Q serves as a planning intraoperative guidance system for the Express Knee, Precision Knee and Versatile Hip offerings. Stryker said it enhances procedural speed and efficiency through a smart, streamlined workflow.

Ortho Q features a robotics-ready platform with dual PCs and a quick-refresh camera. Its implant-agnostic …

July 2023 edition: Life-saving LVADs, supplier innovations and AI breakthroughs

LVADs save lives: So why aren’t more available?

What’s new in 3D printing: medical devices, research, innovation, automation and partnerships

AI breakthroughs in medtech: 7 ways to enhance healthcare

Life-saving LVADs, supplier innovations and AI breakthroughs

Kyree Miller recalls the day his heart stopped beating.

“I remember the entire room going white,” he said. “And I actually turned over on my side and I said, ‘Tell my mom I love her.’”

A couple of weeks later, the heart failure patient — who was only in his 20s at the time — received his first left ventricular assist device (LVAD) implant while he waited for a heart transplant. One year passed, then two, then three. Finally, after surviving on LVAD technology for seven years, his new heart came.

“When you get your transplant, there’s a whole new energy that you get. … But I can honestly say there was a whole new energy that I got when I had my LVAD,” Miller said.

…

CAPA doesn’t have to be a four-letter word, Medtronic Quality/Regulatory Director Kathryn Merrill says

[Illustration by Vitalii Vodolazskyi via Adobe Stock]

Medtronic Quality/Regulatory Program Director Kathryn Merrill is a problem-solver’s problem solver.

Right now, the problem she wants to solve is the way device manufacturers approach corrective and preventative actions — CAPA, an abbreviation that can trigger an avalanche of documentation and headaches for medtech engineers.

For five years, Merrill’s been part of a Medical Device Innovation Consortium (MDIC) team developing a new approach to CAPA, stemming out of conversations across the medtech industry and beyond. The goal was to implement improvements in months instead of years and allow teams to be more proactive.

“I’ve been at Medtronic for 26 years and very often we’d say, ‘Hey, I think we’re making this more complicated than it needs to be,'” said Merrill, who is lead co-author of MDIC̵…